These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase. Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143 [TBL] [Abstract][Full Text] [Related]
23. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). Zucker S; Drews M; Conner C; Foda HD; DeClerck YA; Langley KE; Bahou WF; Docherty AJ; Cao J J Biol Chem; 1998 Jan; 273(2):1216-22. PubMed ID: 9422789 [TBL] [Abstract][Full Text] [Related]
24. Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells. Maquoi E; Frankenne F; Noël A; Krell HW; Grams F; Foidart JM Exp Cell Res; 2000 Dec; 261(2):348-59. PubMed ID: 11112341 [TBL] [Abstract][Full Text] [Related]
25. Rapid trafficking of membrane type 1-matrix metalloproteinase to the cell surface regulates progelatinase a activation. Zucker S; Hymowitz M; Conner CE; DiYanni EA; Cao J Lab Invest; 2002 Dec; 82(12):1673-84. PubMed ID: 12480917 [TBL] [Abstract][Full Text] [Related]
26. Individual Timp deficiencies differentially impact pro-MMP-2 activation. English JL; Kassiri Z; Koskivirta I; Atkinson SJ; Di Grappa M; Soloway PD; Nagase H; Vuorio E; Murphy G; Khokha R J Biol Chem; 2006 Apr; 281(15):10337-46. PubMed ID: 16469749 [TBL] [Abstract][Full Text] [Related]
27. Monocyte membrane type 1-matrix metalloproteinase. Prostaglandin-dependent regulation and role in metalloproteinase-2 activation. Shankavaram UT; Lai WC; Netzel-Arnett S; Mangan PR; Ardans JA; Caterina N; Stetler-Stevenson WG; Birkedal-Hansen H; Wahl LM J Biol Chem; 2001 Jun; 276(22):19027-32. PubMed ID: 11259424 [TBL] [Abstract][Full Text] [Related]
28. Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism. Lafleur MA; Tester AM; Thompson EW FEBS Lett; 2003 Oct; 553(3):457-63. PubMed ID: 14572669 [TBL] [Abstract][Full Text] [Related]
29. Limited processing of pro-matrix metalloprotease-2 (gelatinase A) overexpressed by transfection in PC-3 human prostate tumor cells: association with restricted cell surface localization of membrane-type matrix metalloproteinase-1. Wilson MJ; Jiang A; Wiehr C; Wang X; Sinha AA; Pei D J Androl; 2004; 25(2):274-85. PubMed ID: 14760014 [TBL] [Abstract][Full Text] [Related]
30. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface. Itoh Y; Ito A; Iwata K; Tanzawa K; Mori Y; Nagase H J Biol Chem; 1998 Sep; 273(38):24360-7. PubMed ID: 9733724 [TBL] [Abstract][Full Text] [Related]
31. Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation. Kazes I; Elalamy I; Sraer JD; Hatmi M; Nguyen G Blood; 2000 Nov; 96(9):3064-9. PubMed ID: 11049985 [TBL] [Abstract][Full Text] [Related]
32. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. Sato H; Kinoshita T; Takino T; Nakayama K; Seiki M FEBS Lett; 1996 Sep; 393(1):101-4. PubMed ID: 8804434 [TBL] [Abstract][Full Text] [Related]
33. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. Endo K; Takino T; Miyamori H; Kinsen H; Yoshizaki T; Furukawa M; Sato H J Biol Chem; 2003 Oct; 278(42):40764-70. PubMed ID: 12904296 [TBL] [Abstract][Full Text] [Related]
34. Substrate choice of membrane-type 1 matrix metalloproteinase is dictated by tissue inhibitor of metalloproteinase-2 levels. Kudo T; Takino T; Miyamori H; Thompson EW; Sato H Cancer Sci; 2007 Apr; 98(4):563-8. PubMed ID: 17425593 [TBL] [Abstract][Full Text] [Related]
36. Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase. Wu YI; Munshi HG; Sen R; Snipas SJ; Salvesen GS; Fridman R; Stack MS J Biol Chem; 2004 Feb; 279(9):8278-89. PubMed ID: 14670950 [TBL] [Abstract][Full Text] [Related]
37. Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization. Sounni NE; Baramova EN; Munaut C; Maquoi E; Frankenne F; Foidart JM; Noël A Int J Cancer; 2002 Mar; 98(1):23-8. PubMed ID: 11857380 [TBL] [Abstract][Full Text] [Related]
38. Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. Toth M; Chvyrkova I; Bernardo MM; Hernandez-Barrantes S; Fridman R Biochem Biophys Res Commun; 2003 Aug; 308(2):386-95. PubMed ID: 12901881 [TBL] [Abstract][Full Text] [Related]
39. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. Collen A; Hanemaaijer R; Lupu F; Quax PH; van Lent N; Grimbergen J; Peters E; Koolwijk P; van Hinsbergh VW Blood; 2003 Mar; 101(5):1810-7. PubMed ID: 12393408 [TBL] [Abstract][Full Text] [Related]
40. Complex pattern of membrane type 1 matrix metalloproteinase shedding. Regulation by autocatalytic cells surface inactivation of active enzyme. Toth M; Hernandez-Barrantes S; Osenkowski P; Bernardo MM; Gervasi DC; Shimura Y; Meroueh O; Kotra LP; Gálvez BG; Arroyo AG; Mobashery S; Fridman R J Biol Chem; 2002 Jul; 277(29):26340-50. PubMed ID: 12004057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]